Aptorum Group Ltd reported in its 6-K filing, dated October 15, 2025, that it entered into a merger agreement with DiamiR Biosciences Corp on July 14, 2025, where DiamiR will become a wholly owned subsidiary of Aptorum. The filing includes DiamiR's financial statements for the quarter ended August 31, 2025.